Prudent Use of Compulsory Licensing, Voluntary Licensing and TRIPS waiver in the wake of Covid -19 pandemic: An Indian Perspective

  • Dr. Geni Philipose
  • Show Author Details
  • Dr. Geni Philipose

    Assistant Professor at School of Law, Hindustan Institute of Technology and Science, India

  • img Save PDF

Abstract

The Covid -19 pandemic has changed the lives of many because of its devastating effect. The unprecedented demand for life-saving drugs, equipment needed to save lives has put pressure on every country’s ability to manufacture these essentials on a large scale. People have to be vaccinated to prevent people from being infected. Thus, the nations are exploring various methods to procure and manufacture these vaccines, medicines, and equipment to meet the needs of their citizens. In a vast country like India, the demand is immensely high. This article explores various options India have, such as Compulsory Licensing, Voluntary Licensing, and asking for a TRIPS waiver, in order to procure and manufacture vaccines and medicines.

Type

Research Paper

Information

International Journal of Law Management and Humanities, Volume 4, Issue 5, Page 831 - 843

DOI: https://doij.org/10.10000/IJLMH.111967

Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution -NonCommercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting, and building upon the work for non-commercial use, provided the original work is properly cited.

Copyright

Copyright © IJLMH 2021